Literature DB >> 19342445

Molecular interaction of BMP-4, TGF-beta, and estrogens in lactotrophs: impact on the PRL promoter.

Damiana Giacomini1, Marcelo Páez-Pereda, Johanna Stalla, Günter K Stalla, Eduardo Arzt.   

Abstract

The regulatory role of estrogen, bone morphogenetic protein-4 (BMP-4), and TGF-beta has a strong impact on hormone secretion, gene transcription, and cellular growth of prolactin (PRL)-producing cells. In contrast to TGF-beta, BMP-4 induces the secretion of PRL in GH3 cells. Therefore, we studied the mechanism of their transcriptional regulation. Both BMP-4 and TGF-beta inhibited the transcriptional activity of the estrogen receptor (ER). Estrogens had no effect on TGF-beta-specific Smad protein transcriptional activity but presented a stimulatory action on the transcriptional activity of the BMP-4-specific Smads. BMP-4/estrogen cross talk was observed both on PRL hormone secretion and on the PRL promoter. This cross talk was abolished by the expression of a dominant-negative form for Smad-1 and treatment with ICI 182780 but not by point mutagenesis of the estrogen response element site within the promoter, suggesting that Smad/ER interaction might be dependent on the ER and a Smad binding element. By serial deletions of the PRL promoter, we observed that indeed a region responsive to BMP-4 is located between -2000 and -1500 bp upstream of the transcriptional start site. Chromatin immunoprecipitation confirmed Smad-4 binding to this region, and by specific mutation and gel shift assay, a Smad binding element responsible site was characterized. These results demonstrate that the different transcriptional factors involved in the Smad/ER complexes regulate their transcriptional activity in differential ways and may account for the different regulatory roles of BMP-4, TGF-beta, and estrogens in PRL-producing cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342445      PMCID: PMC5419174          DOI: 10.1210/me.2008-0425

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  71 in total

1.  Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators.

Authors:  J Yanagisawa; Y Yanagi; Y Masuhiro; M Suzawa; M Watanabe; K Kashiwagi; T Toriyabe; M Kawabata; K Miyazono; S Kato
Journal:  Science       Date:  1999-02-26       Impact factor: 47.728

2.  From transforming growth factor-beta signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells.

Authors:  H Y Kang; H K Lin; Y C Hu; S Yeh; K E Huang; C Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

3.  Opposing actions of two transforming growth factor-beta isoforms on pituitary lactotropic cell proliferation.

Authors:  S Hentges; M Pastorcic; A De; N Boyadjieva; D K Sarkar
Journal:  Endocrinology       Date:  2000-04       Impact factor: 4.736

4.  Identification of a third autonomous activation domain within the human estrogen receptor.

Authors:  J D Norris; D Fan; S A Kerner; D P McDonnell
Journal:  Mol Endocrinol       Date:  1997-06

5.  Discrete cis-active genomic sequences dictate the pituitary cell type-specific expression of rat prolactin and growth hormone genes.

Authors:  C Nelson; E B Crenshaw; R Franco; S A Lira; V R Albert; R M Evans; M G Rosenfeld
Journal:  Nature       Date:  1986 Aug 7-13       Impact factor: 49.962

6.  Participation of Smad2, Smad3, and Smad4 in transforming growth factor beta (TGF-beta)-induced activation of Smad7. THE TGF-beta response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regulation.

Authors:  M Stopa; D Anhuf; L Terstegen; P Gatsios; A M Gressner; S Dooley
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

7.  Transforming growth factor beta 1-like immunoreactivity in the pituitary gland of the rat: effect of estrogen.

Authors:  G Burns; D K Sarkar
Journal:  Endocrinology       Date:  1993-09       Impact factor: 4.736

8.  Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk.

Authors:  Marcelo Paez-Pereda; Damiana Giacomini; Damian Refojo; Alberto Carbia Nagashima; Ursula Hopfner; Yvonne Grubler; Alberto Chervin; Victoria Goldberg; Rodolfo Goya; Shane T Hentges; Malcolm J Low; Florian Holsboer; Gunter K Stalla; Eduardo Arzt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

9.  Inhibition of prolactin gene transcription by transforming growth factor-beta in GH3 cells.

Authors:  B C Delidow; W M Billis; P Agarwal; B A White
Journal:  Mol Endocrinol       Date:  1991-11

10.  Roles of the arcuate nucleus and ovary in the maturation of growth hormone, prolactin, and nongranulated cells in the mouse adenohypophysis during postnatal development: a stereological morphometric study by electron microscopy.

Authors:  F Sasaki; M Sano
Journal:  Endocrinology       Date:  1986-10       Impact factor: 4.736

View more
  13 in total

1.  Estrogen inhibits transforming growth factor beta signaling by promoting Smad2/3 degradation.

Authors:  Ichiaki Ito; Aki Hanyu; Mitsutoshi Wayama; Natsuka Goto; Yoko Katsuno; Shohei Kawasaki; Yuka Nakajima; Masashi Kajiro; Yoko Komatsu; Akiko Fujimura; Ryuichi Hirota; Akiko Murayama; Keiji Kimura; Takeshi Imamura; Junn Yanagisawa
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

Review 2.  Unique bioactivities of bone morphogenetic proteins in regulation of reproductive endocrine functions.

Authors:  Fumio Otsuka; Kenichi Inagaki
Journal:  Reprod Med Biol       Date:  2011-04-14

3.  The Local Control of the Pituitary by Activin Signaling and Modulation.

Authors:  Louise M Bilezikjian; Wylie W Vale
Journal:  Open Neuroendocrinol J       Date:  2011-01-01

4.  Fli1 is a negative regulator of estrogen receptor α in dermal fibroblasts.

Authors:  Tomoyasu Hattori; Lukasz Stawski; Sashidhar S Nakerakanti; Maria Trojanowska
Journal:  J Invest Dermatol       Date:  2011-03-31       Impact factor: 8.551

5.  Thrombospondin-1 (TSP-1), a new bone morphogenetic protein-2 and -4 (BMP-2/4) antagonist identified in pituitary cells.

Authors:  Céline Sallon; Isabelle Callebaut; Ida Boulay; Joel Fontaine; Delphine Logeart-Avramoglou; Corinne Henriquet; Martine Pugnière; Xavier Cayla; Philippe Monget; Grégoire Harichaux; Valérie Labas; Sylvie Canepa; Catherine Taragnat
Journal:  J Biol Chem       Date:  2017-07-26       Impact factor: 5.157

6.  Paracrine TGF-β signaling counterbalances BMP-mediated repression in hair follicle stem cell activation.

Authors:  Naoki Oshimori; Elaine Fuchs
Journal:  Cell Stem Cell       Date:  2012-01-06       Impact factor: 24.633

Review 7.  Exposures to synthetic estrogens at different times during the life, and their effect on breast cancer risk.

Authors:  Leena Hilakivi-Clarke; Sonia de Assis; Anni Warri
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-02-08       Impact factor: 2.673

8.  Interaction of TGFβ and BMP signaling pathways during chondrogenesis.

Authors:  Bettina Keller; Tao Yang; Yuqing Chen; Elda Munivez; Terry Bertin; Bernhard Zabel; Brendan Lee
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

9.  The neuroprotective functions of transforming growth factor beta proteins.

Authors:  Arpád Dobolyi; Csilla Vincze; Gabriella Pál; Gábor Lovas
Journal:  Int J Mol Sci       Date:  2012-07-03       Impact factor: 6.208

10.  Altered cytokine gene expression in peripheral blood monocytes across the menstrual cycle in primary dysmenorrhea: a case-control study.

Authors:  Hongyue Ma; Min Hong; Jinao Duan; Pei Liu; Xinsheng Fan; Erxin Shang; Shulan Su; Jianming Guo; Dawei Qian; Yuping Tang
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.